# IMMUNO-XAI Biological Interpretation

## Computational Analysis

- **Pipeline:** IMMUNO-XAI
- **Input cells:** 913
- **LLM:** groq/compound-mini

---

**# 1. Overall Finding**  
- The computational pipeline assigned an immune state to 913 single‑cell transcriptomes.  
- **94.7 % (865 cells)** were labeled **“Insufficient‑Evidence”** (confidence = 0.0).  
- Small fractions were labeled **Immune‑Excluded** (3.5 %, confidence = 1.0), **Immune‑Suppressed** (1.6 %, confidence ≈ 0.78) and a single **Myeloid‑Dominant** cell (≈0.1 % confidence ≈ 0.26).  
- All ten clusters are overwhelmingly composed of Insufficient‑Evidence cells; only a handful of cells in several clusters carry the minority states.  
- Immune‑related activity scores (T‑cell, cytotoxic, myeloid, suppression, inflammatory, antigen‑presentation) have very low means, with most cells scoring = 0 and a few outliers.  
- Pathway scores (glycolysis, oxidative phosphorylation, fatty‑acid metabolism, interferon response, inflammatory signaling, chemokine activity) centre around zero with substantial variability, indicating no consistent pathway activation across the dataset.  
- The machine‑learning classifier is extremely imbalanced (≈ 95 % Insufficient‑Evidence), and SHAP analysis highlights **immune_myeloid_signal** and **immune_immune_suppression** as the most influential features for the model’s decisions.

---

**# 2. Immune‑State Interpretation**  

| Immune state | Cell count | Fraction | Mean confidence |
|--------------|------------|----------|-----------------|
| Insufficient‑Evidence | 865 | 0.947 | 0.0 |
| Immune‑Excluded | 32 | 0.035 | 1.0 |
| Immune‑Suppressed | 15 | 0.016 | 0.78 |
| Myeloid‑Dominant | 1 | 0.001 | 0.26 |

- **Detected states:** The pipeline reliably identifies only three well‑supported states (Immune‑Excluded, Immune‑Suppressed, Myeloid‑Dominant).  
- **Relative abundance:** The vast majority of cells fall into the “Insufficient‑Evidence” category, indicating that the transcriptomic signatures required for confident state assignment are largely absent.  
- **Confidence:** High confidence is only reported for the Immune‑Excluded cells; the suppressed and myeloid‑dominant cells have moderate to low confidence.  
- **Insufficient‑Evidence significance:** This category dominates the dataset, meaning that any biological conclusions about immune composition must be regarded as **limited**; the data do not provide strong evidence for a defined immune landscape.  

Overall, the dataset offers **limited evidence** for distinct immune states; most cells cannot be classified with confidence.

---

**# 3. Cluster‑Level Interpretation**  

- Ten clusters (0‑9) were identified. Every cluster’s **dominant state** is “Insufficient‑Evidence” (≥ 88 % of cells per cluster).  
- Minor contributions of Immune‑Excluded (e.g., 10 cells in cluster 1, 8 cells in cluster 7) and Immune‑Suppressed (e.g., 6 cells in cluster 1, 3 cells in cluster 7) are scattered across clusters without a clear pattern.  
- The single Myeloid‑Dominant cell resides in cluster 2.  
- Mean per‑cluster confidence values are low (0.0–0.11), reinforcing that clusters do not correspond to robustly defined immune phenotypes.  

Because clusters are overwhelmingly composed of Insufficient‑Evidence cells, **no forced biological interpretation** of cluster identity is justified.

---

**# 4. Immune‑Signal Interpretation**  

| Signal | Mean | Median | Std | Max |
|--------|------|--------|-----|-----|
| T‑cell activity | 0.0007 | 0.0 | 0.0218 | 0.658 |
| Cytotoxic activity | 0.0 | 0.0 | 0.0 | 0.0 |
| Myeloid signal | 0.0067 | 0.0 | 0.0288 | 0.295 |
| Immune suppression | 0.0053 | 0.0 | 0.0338 | 0.478 |
| Inflammatory signal | 0.0114 | 0.0 | 0.0749 | 1.393 |
| Antigen presentation | 0.0407 | 0.0 | 0.0665 | 0.413 |

- **General observation:** Scores are near zero for the majority of cells; a few cells exhibit higher values (e.g., inflammatory signal up to 1.39).  
- **Cytotoxic activity** is absent across the dataset.  
- **Myeloid and immune‑suppression signals** show modest mean values but with outliers, aligning with the small number of cells classified as Myeloid‑Dominant or Immune‑Suppressed.  
- **Antigen‑presentation** has the highest mean among the listed scores, yet still low overall.  

These patterns suggest **minimal overall immune activation**, with only sporadic evidence of myeloid or suppressive activity.

---

**# 5. Pathway Interpretation**  

| Pathway | Mean | Median | Std |
|---------|------|--------|-----|
| Glycolysis | 0.0 | –0.0065 | 0.4339 |
| Oxidative phosphorylation | ≈ 0 | 0.0723 | 0.4198 |
| Fatty‑acid metabolism | ≈ 0 | 0.0114 | 0.3554 |
| Interferon response | ≈ 0 | –0.0732 | 0.3308 |
| Inflammatory signaling | ≈ 0 | –0.2428 | 0.4925 |
| Chemokine activity | ≈ 0 | –0.0935 | 0.6230 |

- All pathway scores centre around zero with relatively large standard deviations, indicating **no consistent up‑ or down‑regulation** of these metabolic or inflammatory programs across the cell population.  
- The median values are close to zero (or modestly negative), reinforcing the lack of a dominant pathway signal.  

Thus, the data **do not support strong activation** of any of the listed pathways.

---

**# 6. Machine‑Learning Interpretation**  

- **Prediction count:** 912 cells (one cell appears missing from the ML output).  
- **Class distribution:** 869 % Insufficient‑Evidence, 31 % Immune‑Excluded, 12 % Immune‑Suppressed.  
- **Class imbalance:** The minority classes together represent < 2 % of predictions, which typically leads to inflated overall accuracy but poor sensitivity for the rare states.  
- **Performance metrics:** Not provided; however, given the imbalance, **balanced accuracy** and **minority‑class recall** are likely low.  
- **Interpretation caution:** Predictions for Immune‑Excluded and Immune‑Suppressed should be treated cautiously; the model may be over‑fitting to the dominant class.

---

**# 7. XAI Interpretation**  

- **Top SHAP contributors:**  
  1. `immune_myeloid_signal` (mean |SHAP| = 0.125)  
  2. `immune_immune_suppression` (0.118)  
  3. `immune_antigen_presentation` (0.0236)  
  4–15. Principal components (PC1, PC36, PC39, …) with smaller contributions.  

- **What SHAP tells us:** These features most strongly **influence the model’s output** (i.e., push predictions toward a particular class). The high importance of myeloid and suppression signals aligns with the few cells labelled as Myeloid‑Dominant or Immune‑Suppressed.  

- **Causation disclaimer:** SHAP importance reflects statistical contribution to the classifier, **not** a mechanistic biological cause. The model may rely on these features because they correlate with the limited training labels, not because they drive the underlying biology.

---

**# 8. Integrated Biological Interpretation**  

- The dataset is dominated by cells lacking sufficient transcriptional evidence to assign a defined immune state; consequently, **no robust immune‑state landscape can be inferred**.  
- Low overall immune‑signal scores and near‑zero pathway activity corroborate the lack of strong immune activation.  
- The modest SHAP importance of myeloid and immune‑suppression signals, together with the few cells classified as Immune‑Suppressed or Myeloid‑Dominant, hint at **sporadic, low‑level myeloid or suppressive activity** in a tiny subset of the population.  
- Because the ML model is heavily imbalanced, these minority‑state predictions should be interpreted as **tentative hypotheses** rather than definitive conclusions.  

Overall, the evidence supports **only a weak suggestion of limited myeloid‑related and immune‑suppressive transcriptional activity** in a very small fraction of cells, with the majority of the transcriptome providing insufficient information for confident immune profiling.

---

**# 9. Limitations**  

1. **Insufficient‑Evidence dominance (≈ 95 %)** – the primary limitation; most cells cannot be confidently assigned.  
2. **Low confidence scores** for the few assigned states, especially Myeloid‑Dominant.  
3. **Severe class imbalance** in the ML predictions, likely inflating overall accuracy and reducing reliability for minority classes.  
4. **Zero cytotoxic activity** and generally low immune scores limit the ability to detect active T‑cell or NK‑cell responses.  
5. **Pathway scores are centered near zero** with high variability, preventing definitive statements about metabolic or inflammatory pathway engagement.  
6. **SHAP interpretation is correlational**; high importance does not imply biological causality.  
7. **No external validation** (e.g., protein‑level or functional assays) is provided to corroborate the transcriptomic predictions.  
8. **Sample size (913 cells)** is modest; rare cell states may be under‑sampled.

---

**# 10. Final Conclusion**  
The analysis reveals that the majority of cells lack sufficient transcriptomic evidence to define immune states, with only minimal and low‑confidence indications of myeloid and immune‑suppressive activity in a very small subset.

---

## One-Line Conclusion  
The dataset provides limited evidence of distinct immune states

---

## Interpretation Disclaimer

This report interprets computational single-cell RNA-seq
analysis results. It does not establish causality, clinical
diagnosis, treatment response, or experimental validation.
